These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33664903)
1. Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure. Nakazawa M; Suzuki T; Shiga T; Suzuki A; Hagiwara N J Arrhythm; 2021 Feb; 37(1):196-202. PubMed ID: 33664903 [TBL] [Abstract][Full Text] [Related]
2. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses. Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003 [TBL] [Abstract][Full Text] [Related]
3. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records. Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145 [TBL] [Abstract][Full Text] [Related]
4. Deactivation of implantable defibrillators at the end of life - A register-based study of ICD-deactivation at home and the impact of palliative care. Höijer CJ; Johnson MJ Int J Cardiol; 2023 Sep; 386():91-94. PubMed ID: 37263357 [TBL] [Abstract][Full Text] [Related]
5. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284 [TBL] [Abstract][Full Text] [Related]
6. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Russo JE Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561 [TBL] [Abstract][Full Text] [Related]
7. Defibrillator patients should not be denied a peaceful death. Westerdahl AK; Sutton R; Frykman V Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations. Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823 [TBL] [Abstract][Full Text] [Related]
9. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review. Herman M; Horner K; Ly J; Vayl Y J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615 [TBL] [Abstract][Full Text] [Related]
10. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Herman D; Stros P; Curila K; Kebza V; Osmancik P Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573 [TBL] [Abstract][Full Text] [Related]
11. Improving rates of implantable cardioverter defibrillator deactivation in end-of-life care. Javaid MR; Squirrell S; Farooqi F BMJ Open Qual; 2018; 7(2):e000254. PubMed ID: 29713689 [TBL] [Abstract][Full Text] [Related]
13. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives. Daeschler M; Verdino RJ; Kirkpatrick JN Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265 [TBL] [Abstract][Full Text] [Related]
14. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences. Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436 [TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know? Raphael CE; Koa-Wing M; Stain N; Wright I; Francis DP; Kanagaratnam P Pacing Clin Electrophysiol; 2011 Dec; 34(12):1628-33. PubMed ID: 21955046 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459 [TBL] [Abstract][Full Text] [Related]
17. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure. Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811 [TBL] [Abstract][Full Text] [Related]
19. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study. Thylén I; Moser DK; Strömberg A BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484 [TBL] [Abstract][Full Text] [Related]